Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000943663-17-000106
Filing Date
2017-03-17
Accepted
2017-03-17 14:35:57
Documents
1
Effectiveness Date
2017-03-17
Items
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10169
  Complete submission text file 0000943663-17-000106.txt   11304
Mailing Address 777 THIRD AVENUE 19TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 19TH FLOOR NEW YORK NY 10017 212.698.4595
Innovatus Life Sciences Lending Fund I, LP (Filer) CIK: 0001692825 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-282837 | Film No.: 17697509